Leukotriene B4 mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats

Pancreas

Volumn 40, Issue 5, 2011, Pages 708-714

  Vigna, Steven R ^a   Shahid, Rafiq A ^a   Nathan, Jaimie D ^a   McVey, Douglas C ^a   Liddle, Rodger A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

amylase; capsazepine; MK 886; MPO; pancreas; pancreatitis; rat; TRPV1

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CAPSAZEPINE; LEUKOTRIENE B4; MYELOPEROXIDASE; VANILLOID RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELIAC ARTERY; CONTROLLED STUDY; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID SYNTHESIS; HISTOPATHOLOGY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREAS DUCT LIGATION; PANCREAS DUCT STENOSIS; PANCREAS NECROSIS; PANCREATITIS; PRIORITY JOURNAL; RAT;

ANIMALS; CAPSAICIN; CHOLESTASIS; DISEASE MODELS, ANIMAL; INDOLES; INFLAMMATION MEDIATORS; LEUKOTRIENE B4; LIGATION; LIPOXYGENASE INHIBITORS; MALE; MODELS, BIOLOGICAL; PANCREATITIS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; TRPV CATION CHANNELS;

EID: 79959853945     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318214c8df     Document Type: Article

References (47)

1. Liddle RA, Nathan JD. Neurogenic inflammation and pancreatitis. Pancreatology. 2004;4:551-559. (Pubitemid 40091406)
2. Liddle RA. The role of transient receptor potential vanilloid 1 (TRPV1) channels in pancreatitis. Biochim Biophys Acta. 2007;1772:869-878. (Pubitemid 47176372)
3. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature. 1997;389:816.
4. Szallasi A, DiMarzo V. New perspectives on enigmatic vanilloid receptors. Trends Neurosci. 2000;23:491.
5. Caterina MJ, Julius D. The vanilloid receptor: A molecular gateway to the pain pathway. Ann Rev Neurosci. 2001;24:487-517. (Pubitemid 32695237)
6. Hwang SW, Cho H, Kwak J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc Natl Acad Sci U S A. 2000;97:6155.
7. Saria A, Lundberg JM, Skofitsch G, et al. Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn Schmiedebergs Arch Pharmacol. 1983;324:212-218. (Pubitemid 14247789)
8. Figini M, Emanueli C, Grady EF, et al. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol. 1997;272:G785YG793.
9. Maa J, Grady EF, Kim EH, et al. NK-1 receptor desensitization and neutral endopeptidase terminate SP-induced pancreatic plasma extravasation. Am J Physiol Gastrointest Liver Physiol. 2000;279: G726YG732.
10. Grady EF, Yoshimi SK, Maa J, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol. 2000;130: 505-512. (Pubitemid 30332967)
11. Bhatia M, Saluja AK, Hofbauer B, et al. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A. 1998;95:4760-4765. (Pubitemid 28207987)
12. Nathan JD, Peng RY, McVey DC, et al. Neonatal capsaicin administration ameliorates secretagogue-induced pancreatitis in rats. Surg Forum. 2001;52:23-25.
13. Nathan JD, Peng RY, Wang Y, et al. Primary sensory neuronsVa common final pathway for inflammation in experimental pancreatitis in rats. Am J Physiol. 2002;283:G938YG946. (Pubitemid 35033937)
14. Nathan JD, Patel AA, McVey DC, et al. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol. 2001;281:G1322YG1328.
15. Hutter MM, Wick EC, Day AL, et al. Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R). Pancreas. 2005;30:260-265. (Pubitemid 40397379)
16. Wick EC, Hoge SG, Grahn SW, et al. Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G959YG969.
17. Noble MD, Romac J, Wang Y, et al. Local disruption of the celiac ganglion inhibits substance P release and ameliorates caerulein-induced pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol. 2006;291:G128YG134. (Pubitemid 44024670)
18. Noble MD, Romac J, Vigna SR, et al. A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis. Gut. 2008;57:1566-1571.
19. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature. 1999;400:452-457. (Pubitemid 29361798)
20. Hanus L, Abu-Lafi S, Fride E, et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor. Proc Natl Acad Sci U S A. 2002;98:3662-3665.
21. Huang SM, Bisogno T, Trevisani M, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A. 2002;99:8400-8405. (Pubitemid 34651064)
22. Stenson WF. Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol. 1990;172(suppl): 13-18. (Pubitemid 20206660)
23. Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease Gastroenterology. 1984;86:453-460. (Pubitemid 14154655)
24. Lobos EA, Sharon P, Stenson WF. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4. Dig Dis Sci. 1987;32:1380-1388.
25. Stenson WF, Lobos E. Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils. J Clin Invest. 1982;69:494-497. (Pubitemid 12177629)
26. Sharon P, Stenson WF. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. Gastroenterology. 1985;88:55-63. (Pubitemid 15177640)
27. Wallace JL, MacNaughton WK, Morris GP, et al. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989;96:29-36. (Pubitemid 19046263)
28. Zipser RD, Nast CC, Lee M, et al. In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis. Relationship to inflammation. Gastroenterology. 1987;92:33-39. (Pubitemid 17207658)
29. Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol. 1990;258:G527YG534. (Pubitemid 20144071)
30. McVey DC, Vigna SR. The role of leukotriene B4 in Clostridium difficile toxin AYinduced ileitis in rats. Gastroenterology. 2005;125:1306-1316. (Pubitemid 40712181)
31. Peters-Golden M, Brock TG. 5-Lipoxygenase and FLAP. Prostaglandins Leukot Essent Fatty Acids. 2003;69:99-109. (Pubitemid 36976166)
32. Folch E, Closa D, Prats N, et al. Leukotriene generation and neutrophil infiltration after experimental acute pancreatitis. Inflammation. 1998;22:83-93. (Pubitemid 28065860)
33. Cuzzocrea S, Rossi A, Serraino I, et al. 5-Lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein. Immunology. 2003;110:120-130. (Pubitemid 37059680)
34. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78:206-209. (Pubitemid 12171880)
35. Dawra R, Ku YS, Sharif R, et al. An improved method for extracting myeloperoxidase and determining its activity in the pancreas and lungs during pancreatitis. Pancreas. 2008;37:62-68.
36. Spormann H, Sokolowski A, Letko G. Effect of temporary ischemia upon development and histological patterns of acute pancreatitis in the rat. Pathol Res Pract. 1989;184:507-513. (Pubitemid 19160889)
37. Zingarelli B, Squadrito F, Graziani P, et al. Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats. Agents Actions. 1993;39:150-156. (Pubitemid 23349824)
38. Toda A, Yokomizo T, Shimizu T. Leukotriene B4 receptors. Prostaglandins Other Lipid Mediat. 2002;68-69:575-585.
39. Fretland DJ, Anglin CP, Widomski D, et al. Pharmacological activity of the second generation leukotriene B 4 receptor antagonist, SC-53228: Effects on acute colonic inflammation and hepatic function in rodents. Inflammation. 1995;19:503-515.
40. Ten Hove T, Drillenburg P, Wijnholds J, et al. Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis. Dig Dis Sci. 2002;47:2056-2063. (Pubitemid 35024822)
41. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 1988;24:739-768.
42. Docherty RJ, Yeats JC, Piper AS. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. Br J Pharmacol. 1997;121:1461-1467. (Pubitemid 27317561)
43. Liu L, Simon SA. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. Neurosci Lett. 1997;228:29-32. (Pubitemid 27288529)
44. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev. 1999;51:159-212.
45. Kehrer JP, Biswal SS, La E, et al Inhibition of peroxisome- proliferatorYactivated receptor (PPAR)alpha by MK886. Biochem J. 2001;356:899-906. (Pubitemid 32588464)
46. Genovese T, Mazzon E, Di Paola R, et al. Role of peroxisome proliferatorYactivated receptor-alpha in acute pancreatitis induced by cerulein. Immunology. 2006;118:559-570. (Pubitemid 44079574)
47. Luo M, Lee S, Brock TG. Leukotriene synthesis by epithelial cells. Histol Histopathol. 2003;18:587-595. (Pubitemid 36362076)